医薬品包装市場 : 2027年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年 1月

医薬品包装市場 : 原材料(プラスチック、紙と板紙、ガラス、金属)、タイプ(プラスチックボトル、ブリスター、キャップとクロージャー、ラベルとアクセサリー、プレフィルドシリンジ)、ドラッグデリバリー、地域別 – 2027年までの世界予測
Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region – Global Forecast to 2027

ページ数 315
図表数 327
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global pharmaceutical packaging market size is projected to reach USD 229.9 billion by 2027 from USD 99.9 billion in 2021, at a CAGR of 14.9% during the forecast period.

医薬品包装市場 : 原材料(プラスチック、紙と板紙、ガラス、金属)、タイプ(プラスチックボトル、ブリスター、キャップとクロージャー、ラベルとアクセサリー、プレフィルドシリンジ)、ドラッグデリバリー、地域別 - 2027年までの世界予測 Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027

Primary packaging has the largest market share in 2021. The ever-increasing demand for pharmaceutical packaging in emerging markets owing to rising healthcare expenses, and growing consumer awareness regarding healthier lifestyles. Additionally, the demand for pharma packaging in emerging countries such as Asia Pacific, South America and Middle East & Africa, is increasing due to large investments by governments to provide better access to healthcare and rising occurrences of chronic diseases such as cancer, infectious diseases, and others are also expected to drive the market for pharmaceutical packaging during the forecast period.
Paper & Paper board accounted for the second largest share amongst other raw materials in the pharmaceutical packaging market
Paper & paperboard have significant demand for use as medicine labels and secondary containers. These packagings engages customers and provide vital information of the product being packed inside through use of high-end graphics as well as enables full structural support. Paper board sheets are cut, folded, and bonded into the appropriate shape. Corners may be strengthened depending on the need, the material can be produced as set-up paperboard boxes, folding cartons, or trays. It offers comfort, sturdiness, and effective product protection
Blister accounted for the second largest market share amongst other types in the pharmaceutical packaging market
Blister packs are made from thermoformed plastics and generally have paperboard or aluminum backing/lidding. The aluminum lids are coated with adhesives and are applied over the blister packs by heating thereby forming a sealed package. Blister packs protect the medicine form external factors such as moisture, contamination, UV rays and others. Blister packs also provide efficient and safe drug delivery for oral solid doses or capsules.
Injectable is expected to be the second largest pharmaceutical packaging drug delivery mode in 2021 amongst others.
Injectable drug delivery systems are considered as one of the most effective and successful routes of drug administration owing to its speed and efficacy to reach the target area. The majority of drugs are delivered orally or by injections. Injectables are available as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and others. Advancements in technology have resulted in development of wide range of improved and enhanced devices. In addition, development of the biologics market is expected to boost the market for injectables during the forecast period.
South America is projected to grow the second fastest in the pharmaceutical packaging market during the forecast period.
South America is predicted to be the second fastest growing region amongst others in the pharmaceutical packaging market in 2021, in terms of value. Brazil and Argentina are the key markets in the region and are undergoing high growth rates. With the rising disposable incomes, increasing demand for pharmaceuticals, aging population, and improved government policies, the pharmaceutical packaging market is poised to grow further in the next five years. The growth in the production of generic drugs, cheaper production costs, and quality assurance are driving the market for plastic bottles and oral delivery systems in this region.
Extensive primary interviews were conducted in the process of determining and verifying sizes of several segments and subsegments of the pharmaceutical packaging market gathered through secondary research.
The breakdown of primary interviews has been given below.
• By Company Type: Tier 1 – 25%, Tier 2 – 50%, and Tier 3 – 25%
• By Designation: C Level Executives – 20%, Director Level – 30%, Others – 50%
• By Region: North America – 20%, Asia Pacific – 25%, Europe – 30%, Middle East & Africa – 10%, South America-15%.
The key players in this market are Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, agreements, partnerships, and mergers & acquisitions to strengthen their market positions.

医薬品包装市場 : 原材料(プラスチック、紙と板紙、ガラス、金属)、タイプ(プラスチックボトル、ブリスター、キャップとクロージャー、ラベルとアクセサリー、プレフィルドシリンジ)、ドラッグデリバリー、地域別 - 2027年までの世界予測 Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027
Research Coverage
This report provides detailed segmentation of the pharmaceutical packaging market and forecasts its market size until 2027. The market has been segmented based on raw material, type, drug delivery, and region. The report also provides detailed information on company profiles and competitive strategies adopted by the key players to strengthen their positions in the market. The report also provides insights into the driving and restraining factors in the pharmaceutical packaging market, along with opportunities and challenges across these industries. It also includes profiles for top manufacturers in the market.
Reasons to Buy the Report
From an insight perspective, this research report focuses on various levels of analyses — industry analysis (industry trends), market ranking of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the pharmaceutical packaging market; high growth regions; and market drivers, restraints, opportunities, and challenges.


目次

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 39
1.3.1 REGIONS COVERED 39
1.3.2 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED 40
1.5 UNIT CONSIDERED 40
1.6 STAKEHOLDERS 40
1.7 INCLUSIONS & EXCLUSIONS 41
TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS 41
1.8 SUMMARY OF CHANGES 42
1.9 LIMITATIONS 42
2 RESEARCH METHODOLOGY 43
2.1 IMPACT OF RECESSION 43
2.2 RESEARCH DATA 43
FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 44
2.2.1 SECONDARY DATA 44
2.2.1.1 Major secondary sources 45
2.2.1.2 Key data from secondary sources 45
2.2.2 PRIMARY DATA 46
2.2.3 PRIMARY INTERVIEWS 46
2.2.3.1 Demand and supply sides 46
2.2.3.2 Key data from primary sources 47
2.2.3.3 Key industry insights 47
2.2.3.4 Breakdown of primary interviews 48
2.3 MARKET SIZE ESTIMATION 48
2.3.1 BOTTOM-UP APPROACH 49
FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH 49
2.4 DATA TRIANGULATION 50
FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 50
2.4.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS 51
2.4.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES 51
FIGURE 6 PHARMACEUTICAL PACKAGING MARKET ANALYSIS 52
2.5 RESEARCH LIMITATIONS 52
2.6 RESEARCH ASSUMPTIONS 53
2.7 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 53
2.7.1 SUPPLY SIDE 53
2.7.2 DEMAND SIDE 54
2.7.3 INSIGHTS FROM KEY RESPONDENTS 54
2.8 RISK ASSESSMENT 55
3 EXECUTIVE SUMMARY 56
FIGURE 7 PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING 57
FIGURE 8 PLASTICS TO BE LARGEST RAW MATERIAL FOR PHARMACEUTICAL PACKAGING 58
FIGURE 9 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT OF PHARMACEUTICAL PACKAGING MARKET 58
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET 59
4 PREMIUM INSIGHTS 60
4.1 EMERGING ECONOMIES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 60
FIGURE 11 ASIA PACIFIC TO OFFER ATTRACTIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET 60
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 61
FIGURE 12 PLASTIC BOTTLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 61
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 61
FIGURE 13 PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 61
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE 62
FIGURE 14 ORAL DRUG DELIVERY MODE TO LEAD MARKET BY 2027 62
4.5 GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY 62
FIGURE 15 MARKET IN INDIA TO GROW AT HIGHEST CAGR 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET 63
5.2.1 DRIVERS 64
5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies 64
5.2.1.2 Rising demand for drug delivery devices and blister packaging 65
5.2.1.3 Technological advancements 66
5.2.1.3.1 Nanomedicine and nano drug delivery systems (NDDS) 66
5.2.1.3.2 Child-resistant packaging (CRP) 66
5.2.1.3.3 Radio-frequency identification (RFID) 66
5.2.1.3.4 Micropump technology 67
5.2.1.3.5 Eco-friendly and sustainable packaging 67
5.2.2 RESTRAINTS 67
5.2.2.1 Increasing overall packaging costs due to dynamic regulatory policies 67
5.2.2.2 Lack of access to proper healthcare in emerging economies 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Growing demand for primary pharmaceutical packaging 68
5.2.4 CHALLENGES 69
5.2.4.1 Safeguarding against counterfeit products 69
5.3 VALUE CHAIN ANALYSIS 70
FIGURE 17 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 70
5.3.1 RAW MATERIAL SUPPLIERS 70
5.3.2 R&D OF PRODUCTS 71
5.3.3 MANUFACTURERS 71
5.3.4 DISTRIBUTORS 71
5.3.5 END USERS 71
TABLE 2 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN STAKEHOLDERS 72
5.4 PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET 73
5.4.1 THREAT OF NEW ENTRANTS 73
5.4.2 THREAT OF SUBSTITUTES 74
5.4.3 BARGAINING POWER OF BUYERS 74
5.4.4 BARGAINING POWER OF SUPPLIERS 74
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 75
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET 75
5.5 MACROECONOMIC INDICATORS 75
5.5.1 GLOBAL GDP TRENDS 75
TABLE 4 TRENDS OF PER CAPITA GDP (USD) 2019–2021 75
TABLE 5 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027 76
TABLE 6 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2019 77
5.6 REGULATORY LANDSCAPE 78
5.6.1 REGULATIONS 78
5.6.1.1 Europe 78
5.6.1.2 US 78
5.6.1.3 Others 78
5.7 TECHNOLOGY ANALYSIS 79
5.7.1 NANOTECHNOLOGY 79
5.7.2 PACKAGING FOR BIOLOGICS 79
5.7.3 SMART PACKAGING 79
5.7.4 ANTI-COUNTERFEIT PACKAGING 79
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES 80
5.8 PRICING ANALYSIS 80
5.8.1 AVERAGE SELLING PRICE, BY REGION 80
FIGURE 19 AVERAGE SELLING PRICE, BY REGION (USD/KG) 80
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 81
TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 81
5.8.3 AVERAGE SELLING PRICE, BY COMPANY 81
TABLE 8 AVERAGE SELLING PRICE, BY COMPANY (USD/KG) 81
5.9 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 82
FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 82
5.10 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 83
5.10.1 IMPACT ON HEALTHCARE INDUSTRY 83
5.11 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 84
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 84
FIGURE 21 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE GROWTH 84
5.13 PATENT ANALYSIS 85
5.13.1 INTRODUCTION 85
5.13.2 METHODOLOGY 85
5.13.3 DOCUMENT TYPE 85
FIGURE 22 PATENTS REGISTERED (2011–2021) 85
5.13.4 PUBLICATION TRENDS – LAST 10 YEARS 86
FIGURE 23 NUMBER OF PATENTS IN LAST 10 YEARS, 2011–2021 86
5.13.5 INSIGHTS 86
5.13.6 JURISDICTION ANALYSIS 86
FIGURE 24 TOP JURISDICTIONS 86
5.13.7 TOP PATENT APPLICANTS 87
FIGURE 25 TOP 10 PATENT APPLICANTS 87
TABLE 9 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND 88
TABLE 10 LIST OF PATENTS BY SCHOTT AG 88
TABLE 11 LIST OF PATENTS BY TERUMO CORP 89
TABLE 12 LIST OF PATENTS BY BECTON DICKINSON AND COMPANY 90
TABLE 13 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 90
5.14 RAW MATERIAL ANALYSIS 91
5.14.1 PLASTICS 91
5.14.2 PAPER 91
5.14.3 GLASS 91
5.14.4 METALS 91
5.15 TRADE ANALYSIS 92
5.16 OPERATIONAL DATA 93
5.17 KEY CONFERENCES AND EVENTS (2022–2023) 93
TABLE 14 KEY CONFERENCES AND EVENTS (2022–2023) 93

5.18 CASE STUDY ANALYSIS 94
5.18.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 94
5.18.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING 95
6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 96
6.1 INTRODUCTION 97
FIGURE 26 PLASTICS SEGMENT TO DOMINATE PHARMACEUTICAL PACKAGING MARKET 97
TABLE 15 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 97
TABLE 16 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 98
TABLE 17 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 99
TABLE 18 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 99
TABLE 19 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 99
TABLE 20 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 100
TABLE 21 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 100
TABLE 22 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 100
TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 101
6.2 PLASTICS 101
6.2.1 EXCELLENT SHATTER RESISTANCE OF PLASTICS TO BOOST ITS USE IN PRIMARY PACKAGING 101
TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 101
TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 102
TABLE 26 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 102
TABLE 27 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 102
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE) 103
6.2.3 POLYESTER 103
6.2.4 POLYPROPYLENE (PP) 103
6.2.5 LOW-DENSITY POLYETHYLENE (LDPE) 103
6.2.6 POLYVINYL CHLORIDE (PVC) 103
6.2.7 CYCLIC OLEFIN COPOLYMER (COC) 104
6.2.8 POLYETHYLENE TEREPHTHALATE (PET) 104

6.3 PAPER & PAPERBOARD 104
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL USE OF PAPER & PAPERBOARD 104
TABLE 28 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 105
TABLE 29 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 105
TABLE 30 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 105
TABLE 31 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 106
6.4 GLASS 106
6.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING 106
TABLE 32 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 107
TABLE 33 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 107
TABLE 34 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 107
TABLE 35 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 108
TABLE 36 TYPES OF GLASS USED FOR DIFFERENT PACKAGING 109
6.5 METALS 109
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO BOOST MARKET 109
TABLE 37 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 110
TABLE 38 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 110
TABLE 39 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 110
TABLE 40 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 111
6.6 OTHERS 111
TABLE 41 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 112
TABLE 42 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 112
TABLE 43 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 112
TABLE 44 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 113

7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 114
7.1 INTRODUCTION 115
FIGURE 27 PLASTIC BOTTLES ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL PACKAGING MARKET 115
TABLE 45 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 116
TABLE 46 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 117
TABLE 47 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 117
TABLE 48 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 117
7.2 PLASTIC BOTTLES 118
7.2.1 EASY OPERABILITY, SHATTER RESISTANCE, AND LIGHTWEIGHT PROPERTIES TO DRIVE DEMAND 118
TABLE 49 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 118
TABLE 50 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 119
7.2.2 STANDARD PLASTIC BOTTLES 119
7.2.3 PLASTIC DISPENSING BOTTLES 119
7.2.4 PLASTIC JARS 119
7.3 BLISTER PACKS 119
7.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE MARKET 119
TABLE 51 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 120
TABLE 52 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 120
7.3.2 COMPARTMENT PACKS 120
7.3.3 WALLET PACKS 120
7.4 LABELS & ACCESSORIES 121
7.4.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO BOOST DEMAND 121
TABLE 53 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 121
TABLE 54 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 121
7.4.2 SELF-ADHESIVE LABELS 122
7.4.3 DIE-CUT LABELS 122
7.4.4 TAMPER-PROOF LABELS 122
7.4.5 HOLOGRAPHIC STRIP LABELS 122

7.5 CAPS & CLOSURES 122
7.5.1 DEMAND FOR TAMPER-EVIDENT PACKAGING TO PROPEL MARKET 122
TABLE 55 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 123
TABLE 56 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 123
7.6 MEDICAL SPECIALTY BAGS 123
7.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS TO FUEL DEMAND 123
TABLE 57 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 124
TABLE 58 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 124
7.7 PREFILLED SYRINGES 124
7.7.1 SELF-MEDICATION AND INCREASING CHRONIC DISEASES TO DRIVE DEMAND 124
TABLE 59 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 125
TABLE 60 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 125
7.8 TEMPERATURE-CONTROLLED PACKAGING 126
7.8.1 INCREASING MANUFACTURING OF SPECIALIZED DRUGS TO FUEL MARKET 126
TABLE 61 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 126
TABLE 62 TEMPERATURE CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 126
7.9 POUCHES & STRIP PACKS 127
7.9.1 INCREASING DEMAND FOR STANDUP POUCHES TO OFFER GROWTH OPPORTUNITIES 127
TABLE 63 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 127
TABLE 64 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 127
7.10 AMPOULES 128
7.10.1 INCREASING DEMAND FROM DEVELOPING COUNTRIES TO DRIVE MARKET 128
TABLE 65 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 128
TABLE 66 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 128
7.11 VIALS 129
7.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO SUPPORT MARKET GROWTH 129
TABLE 67 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 129
TABLE 68 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 129
7.12 PREFILLED INHALERS 130
7.12.1 INCREASING CASES OF PULMONARY DISEASES TO DRIVE DEMAND 130
TABLE 69 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE,
BY REGION, 2018–2021 (USD MILLION) 130
TABLE 70 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 130
7.12.2 METERED DOSE INHALERS 131
7.12.3 DRY POWDER INHALERS 131
7.13 MEDICATION TUBES 131
7.13.1 EASE OF USE TO INCREASE DEMAND 131
TABLE 71 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 131
TABLE 72 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 132
7.13.2 COMPOSITE TUBES 132
7.13.3 ALL-PLASTIC TUBES 132
7.13.4 COLLAPSIBLE METAL TUBES 132
7.14 JARS & CANISTERS 132
7.14.1 EFFECTIVE BARRIER PROPERTIES TO PROPEL DEMAND 132
TABLE 73 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 133
TABLE 74 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 133
7.15 CARTRIDGES 133
7.15.1 COMPATIBILITY WITH A VARIETY OF DEVICES TO DRIVE MARKET 133
TABLE 75 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 76 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 134
7.16 OTHERS 134
TABLE 77 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 78 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 135
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE 136
8.1 INTRODUCTION 137
FIGURE 28 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT IN 2022 137
TABLE 79 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 138
TABLE 80 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 138
TABLE 81 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2018–2021 (USD MILLION) 138
TABLE 82 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2022–2027 (USD MILLION) 139
8.2 ORAL DRUG DELIVERY MODE 139
8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY MODE OWING TO EASE OF USE 139
TABLE 83 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 140
TABLE 84 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 140
8.3 INJECTABLE DRUG DELIVERY MODE 140
8.3.1 HIGH BIOAVAILABILITY AND EFFICIENT TREATMENT TO BOOST THIS SEGMENT 140
TABLE 85 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 141
TABLE 86 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 141
8.4 TOPICAL DRUG DELIVERY MODE 141
8.4.1 PREVALENCE OF SKIN DISEASES TO DRIVE MARKET FOR TOPICAL FORMULATIONS 141
TABLE 87 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 142
TABLE 88 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 142
8.5 OCULAR/OPHTHALMIC DRUG DELIVERY MODE 142
8.5.1 INCREASING PREVALENCE OF EYE DISORDERS AND AGING POPULATION TO FUEL CONSUMPTION 142
TABLE 89 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 143
TABLE 90 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 143
8.6 NASAL DRUG DELIVERY MODE 143
8.6.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION TO PROPEL MARKET 143
TABLE 91 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 144
TABLE 92 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 144
8.7 PULMONARY DRUG DELIVERY MODE 145
8.7.1 INCREASING CASES OF LUNG-RELATED DISEASES TO BOOST DEMAND 145
TABLE 93 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 145
TABLE 94 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 146
8.8 TRANSDERMAL DRUG DELIVERY MODE 146
8.8.1 INCREASING SMALL-DOSE DRUG USE TO FUEL MARKET 146
TABLE 95 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 147
TABLE 96 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 147
8.9 IV DRUG DELIVERY MODE 147
8.9.1 IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY TO DRIVE DEMAND 147
TABLE 97 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 148
TABLE 98 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 148
8.10 OTHER DRUG DELIVERY MODES 148
TABLE 99 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 149
TABLE 100 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 149
9 PHARMACEUTICAL PACKAGING MARKET, BY REGION 150
9.1 INTRODUCTION 151
FIGURE 29 PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR 151
TABLE 101 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 151
TABLE 102 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 152
9.2 NORTH AMERICA 152
9.2.1 RECESSION IMPACT 152
FIGURE 30 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 153
TABLE 103 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 153
TABLE 104 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 154
TABLE 105 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 154
TABLE 106 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 155
TABLE 107 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 155
TABLE 108 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 155
TABLE 109 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 156
TABLE 110 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 156
TABLE 111 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 157
TABLE 112 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 157
TABLE 113 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 157
TABLE 114 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 158
9.2.2 US 158
9.2.2.1 Rapid technological advancements 158
TABLE 115 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 159
TABLE 116 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 160
9.2.3 CANADA 160
9.2.3.1 Competitive business environment to boost market 160
TABLE 117 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 161
TABLE 118 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 162
9.2.4 MEXICO 162
9.2.4.1 Government initiatives in healthcare industry to fuel demand 162
TABLE 119 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 163
TABLE 120 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 164
9.3 EUROPE 164
9.3.1 RECESSION IMPACT 165
TABLE 121 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 165
TABLE 122 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 165
TABLE 123 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 166
TABLE 124 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 167
TABLE 125 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 167
TABLE 126 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 167
TABLE 127 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 168
TABLE 128 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 168
TABLE 129 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 169
TABLE 130 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 169
TABLE 131 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 169
TABLE 132 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 170
9.3.2 GERMANY 170
9.3.2.1 Increase in aging population and non-communicable diseases to drive market 170
TABLE 133 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 171
TABLE 134 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 172
9.3.3 FRANCE 172
9.3.3.1 High demand for generic drugs to drive market 172
TABLE 135 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 173
TABLE 136 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 174
9.3.4 ITALY 174
9.3.4.1 Growing exports of pharmaceuticals to impact market growth 174
TABLE 137 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 175
TABLE 138 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 176
9.3.5 UK 176
9.3.5.1 Innovation in drug manufacturing to increase demand 176
TABLE 139 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 177
TABLE 140 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 178
9.3.6 SPAIN 178
9.3.6.1 Government initiatives in healthcare sector to boost demand 178
TABLE 141 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 179
TABLE 142 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 180
9.3.7 RUSSIA 180
9.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 180
TABLE 143 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 181
TABLE 144 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 182
9.3.8 REST OF EUROPE 182
TABLE 145 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 183
TABLE 146 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 184
9.4 ASIA PACIFIC 184
9.4.1 RECESSION IMPACT 184
FIGURE 31 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 185
TABLE 147 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 186
TABLE 148 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 186
TABLE 149 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 187
TABLE 150 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 188
TABLE 151 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 188
TABLE 152 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 188
TABLE 153 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 189
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 189
TABLE 155 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 190
TABLE 156 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 190
TABLE 157 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 190
TABLE 158 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 191
9.4.2 CHINA 191
9.4.2.1 Increased investments in R&D of biologics and biosimilar drugs to drive market 191
TABLE 159 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 192
TABLE 160 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 193
9.4.3 JAPAN 193
9.4.3.1 Sizeable aging population to drive demand for medications 193
TABLE 161 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 194
TABLE 162 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 195
9.4.4 SOUTH KOREA 195
9.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market 195
TABLE 163 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 196
TABLE 164 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 197
9.4.5 INDIA 197
9.4.5.1 Large domestic consumption and export of generic drugs to drive market 197
TABLE 165 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 199
TABLE 166 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 200
9.4.6 AUSTRALIA 200
9.4.6.1 Medicare and PBS schemes strengthening country’s pharmaceutical industry to drive market 200
TABLE 167 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 201
TABLE 168 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 202
9.4.7 REST OF ASIA PACIFIC 202
TABLE 169 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 203
TABLE 170 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 204
9.5 SOUTH AMERICA 204
9.5.1 RECESSION IMPACT 205
TABLE 171 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 205
TABLE 172 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 205
TABLE 173 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 206
TABLE 174 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 207
TABLE 175 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 207
TABLE 176 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 207
TABLE 177 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 208
TABLE 178 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 208
TABLE 179 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 209
TABLE 180 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 209
TABLE 181 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 209
TABLE 182 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 210
9.5.2 BRAZIL 210
9.5.2.1 Free and universal healthcare services to support growth of pharmaceutical industry 210
TABLE 183 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 211
TABLE 184 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 212
9.5.3 ARGENTINA 212
9.5.3.1 Plastic bottles to account for largest market share 212
TABLE 185 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 213
TABLE 186 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 214
9.5.4 REST OF SOUTH AMERICA 214
TABLE 187 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 215
TABLE 188 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 216
9.6 MIDDLE EAST & AFRICA 216
9.6.1 RECESSION IMPACT 217
TABLE 189 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 217
TABLE 190 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 217
TABLE 191 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 218
TABLE 192 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 219
TABLE 193 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 219
TABLE 194 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 219
TABLE 195 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 220
TABLE 196 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 220
TABLE 197 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 221
TABLE 198 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 221
TABLE 199 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 221
TABLE 200 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 222
9.6.2 SAUDI ARABIA 222
9.6.2.1 Wider access to healthcare services to increase demand for pharmaceuticals 222
TABLE 201 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 223
TABLE 202 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 224
9.6.3 SOUTH AFRICA 224
9.6.3.1 Gradual rise in generic drug use to fuel pharmaceutical packaging market 224
TABLE 203 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 225
TABLE 204 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 226
9.6.4 UAE 226
9.6.4.1 Increasing initiatives for domestic pharmaceutical production to drive market 226
TABLE 205 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 227
TABLE 206 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 228
9.6.5 REST OF MIDDLE EAST & AFRICA 228
TABLE 207 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 229
TABLE 208 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 230

10 COMPETITIVE LANDSCAPE 231
10.1 OVERVIEW 231
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 232
FIGURE 32 COMPANIES ADOPTED INVESTMENT & EXPANSION AND NEW PRODUCT DEVELOPMENT AS KEY GROWTH STRATEGIES 232
10.3 MARKET EVALUATION MATRIX 233
TABLE 209 MARKET EVALUATION MATRIX 234
10.4 REVENUE ANALYSIS 234
TABLE 210 REVENUE OF KEY COMPANIES IN LAST THREE YEARS 234
10.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 235
FIGURE 33 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2021 235
10.5.1 BERRY GLOBAL INC. 235
10.5.2 AMCOR PLC 235
10.5.3 APTARGROUP, INC. 235
10.5.4 GERRESHEIMER AG 236
10.5.5 SCHOTT AG 236
10.6 MARKET SHARE ANALYSIS 236
FIGURE 34 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021) 236
TABLE 211 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 237
10.7 COMPANY EVALUATION MATRIX (TIER 1) 237
10.7.1 STARS 237
10.7.2 PERVASIVE PLAYERS 237
10.7.3 EMERGING LEADERS 237
10.7.4 PARTICIPANTS 237
FIGURE 35 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER 1 COMPANIES, 2021 238
10.8 STRENGTH OF PRODUCT PORTFOLIO 239
10.9 BUSINESS STRATEGY EXCELLENCE 239
10.10 COMPANY EVALUATION MATRIX (START-UPS AND SMES) 240
10.10.1 PROGRESSIVE COMPANIES 240
10.10.2 RESPONSIVE COMPANIES 240
10.10.3 STARTING BLOCKS 240
10.10.4 DYNAMIC COMPANIES 240
FIGURE 36 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021 241
10.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 242
10.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 243
10.13 COMPETITIVE BENCHMARKING 243
TABLE 212 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF COMPANIES 243
10.13.1 COMPANY DRUG DELIVERY MODE FOOTPRINT 245
TABLE 213 OVERALL DRUG DELIVERY MODE FOOTPRINT 245
10.13.2 COMPANY TYPE FOOTPRINT 246
TABLE 214 OVERALL TYPE FOOTPRINT 246
10.13.3 COMPANY REGION FOOTPRINT 248
TABLE 215 OVERALL REGION FOOTPRINT 248
10.13.4 COMPANY FOOTPRINT 249
TABLE 216 OVERALL COMPANY FOOTPRINT 249
10.14 COMPETITIVE SITUATION AND TRENDS 250
10.14.1 PRODUCT LAUNCHES 250
TABLE 217 PHARMACEUTICAL PACKAGING: PRODUCT LAUNCHES, 2018–NOVEMBER 2022 250
10.14.2 DEALS 254
TABLE 218 PHARMACEUTICAL PACKAGING: DEALS, 2018–NOVEMBER 2022 254
10.14.3 OTHERS 256
TABLE 219 PHARMACEUTICAL PACKAGING MARKET: OTHERS, 2018–NOVEMBER 2022 256
11 COMPANY PROFILES 262
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 BERRY GLOBAL INC. 262
TABLE 220 BERRY GLOBAL: COMPANY OVERVIEW 262
FIGURE 37 BERRY GLOBAL: COMPANY SNAPSHOT 263
TABLE 221 BERRY GLOBAL: PRODUCTS OFFERED 263
TABLE 222 BERRY GLOBAL: PRODUCT LAUNCHES 264
TABLE 223 BERRY GLOBAL: DEALS 264
TABLE 224 BERRY GLOBAL: OTHER DEVELOPMENTS 265
11.2 GERRESHEIMER AG 266
TABLE 225 GERRESHEIMER AG: COMPANY OVERVIEW 266
FIGURE 38 GERRESHEIMER AG: COMPANY SNAPSHOT 267
TABLE 226 GERRESHEIMER AG: PRODUCTS OFFERED 268
TABLE 227 GERRESHEIMER AG: PRODUCT LAUNCHES 269
TABLE 228 GERRESHEIMER AG: OTHER DEVELOPMENTS 270
11.3 AMCOR PLC 272
TABLE 229 AMCOR PLC: COMPANY OVERVIEW 272
FIGURE 39 AMCOR: COMPANY SNAPSHOT 273
TABLE 230 AMCOR: PRODUCTS OFFERED 273
TABLE 231 AMCOR: PRODUCT LAUNCHES 275
TABLE 232 AMCOR: DEALS 275
TABLE 233 AMCOR: OTHER DEVELOPMENTS 276

11.4 SCHOTT AG 277
TABLE 234 SCHOTT AG: COMPANY OVERVIEW 277
FIGURE 40 SCHOTT AG: COMPANY SNAPSHOT 278
TABLE 235 SCHOTT AG: PRODUCTS OFFERED 278
TABLE 236 SCHOTT AG: PRODUCT LAUNCHES 279
TABLE 237 SCHOTT AG: DEALS 279
TABLE 238 SCHOTT AG: OTHER DEVELOPMENTS 280
11.5 APTARGROUP, INC. 282
TABLE 239 APTARGROUP, INC.: COMPANY OVERVIEW 282
FIGURE 41 APTARGROUP: COMPANY SNAPSHOT 283
TABLE 240 APTARGROUP: PRODUCTS OFFERED 283
TABLE 241 APTARGROUP: PRODUCT LAUNCHES 284
TABLE 242 APTARGROUP: DEALS 285
TABLE 243 APTARGROUP: OTHER DEVELOPMENTS 285
11.6 BECTON, DICKINSON AND COMPANY 287
TABLE 244 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 287
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 287
TABLE 245 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 288
TABLE 246 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES 288
TABLE 247 BECTON, DICKINSON AND COMPANY: DEALS 289
TABLE 248 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS 289
11.7 WESTROCK COMPANY 290
TABLE 249 WESTROCK COMPANY: COMPANY OVERVIEW 290
FIGURE 43 WESTROCK COMPANY: COMPANY SNAPSHOT 291
TABLE 250 WESTROCK COMPANY: PRODUCTS OFFERED 291
TABLE 251 WESTROCK COMPANY: OTHER DEVELOPMENTS 292
11.8 NIPRO CORPORATION 293
TABLE 252 NIPRO CORPORATION: COMPANY OVERVIEW 293
FIGURE 44 NIPRO CORPORATION: COMPANY SNAPSHOT 293
TABLE 253 NIPRO CORPORATION: PRODUCTS OFFERED 294
TABLE 254 NIPRO CORPORATION: DEALS 294
11.9 CATALENT, INC. 295
TABLE 255 CATALENT, INC.: COMPANY OVERVIEW 295
FIGURE 45 CATALENT: COMPANY SNAPSHOT 295
TABLE 256 CATALENT: PRODUCTS OFFERED 296
TABLE 257 CATALENT: DEALS 296
TABLE 258 CATALENT: OTHER DEVELOPMENTS 297
11.10 SEALED AIR 298
TABLE 259 SEALED AIR: COMPANY OVERVIEW 298
FIGURE 46 SEALED AIR: COMPANY SNAPSHOT 298
TABLE 260 SEALED AIR: PRODUCTS OFFERED 299
TABLE 261 SEALED AIR: PRODUCT LAUNCHES 299
TABLE 262 SEALED AIR: DEALS 300
11.11 WEST PHARMACEUTICAL SERVICES, INC. 301
TABLE 263 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 301
FIGURE 47 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT 301
TABLE 264 WEST PHARMACEUTICAL SERVICES: PRODUCTS OFFERED 302
TABLE 265 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES 302
TABLE 266 WEST PHARMACEUTICAL SERVICES: OTHER DEVELOPMENTS 303
11.12 OTHERS 304
11.12.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG 304
TABLE 267 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW 304
11.12.2 ARDAGH GROUP S.A. 305
TABLE 268 ARDAGH GROUP S.A.: COMPANY OVERVIEW 305
11.12.3 CCL INDUSTRIES INC. 306
TABLE 269 CCL INDUSTRIES INC.: COMPANY OVERVIEW 306
11.12.4 FRANK NOE EGYPT LTD. 307
TABLE 270 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW 307
11.12.5 GAPLAST GMBH 308
TABLE 271 GAPLAST GMBH: COMPANY OVERVIEW 308
11.12.6 LONZA GROUP LTD. 309
TABLE 272 LONZA GROUP LTD.: COMPANY OVERVIEW 309
11.12.7 MONDI GROUP 310
TABLE 273 MONDI GROUP: COMPANY OVERVIEW 310
11.12.8 NOLATO AB 311
TABLE 274 NOLATO AB: COMPANY OVERVIEW 311
11.12.9 ORIGIN PHARMA PACKAGING 312
TABLE 275 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW 312
11.12.10 COMAR 313
TABLE 276 COMAR: COMPANY OVERVIEW 313
11.12.11 BILCARE LIMITED 314
TABLE 277 BILCARE LIMITED: COMPANY OVERVIEW 314
11.12.12 SGD PHARMA 315
TABLE 278 SGD PHARMA: COMPANY OVERVIEW 315
11.12.13 SILGAN HOLDINGS INC. 316
TABLE 279 SILGAN HOLDINGS INC.: COMPANY OVERVIEW 316
11.12.14 VETTER PHARMA INTERNATIONAL GMBH 317
TABLE 280 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW 317
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 318
12.1 DISCUSSION GUIDE 318
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322
12.3 CUSTOMIZATION OPTIONS 324
12.4 RELATED REPORTS 324
12.5 AUTHOR DETAILS 325


    お問合せフォーム

    • レポートのタイトルは自動で入ります。

    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com